Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109


Genetic nurse counsellors can be an acceptable and cost-effective alternative to clinical geneticists for breast cancer risk genetic counselling. Evidence from two parallel randomised controlled equivalence trials.

Torrance N, Mollison J, Wordsworth S, Gray J, Miedzybrodzka Z, Haites N, Grant A, Campbell M, Watson MS, Clarke A, Wilson B.

Br J Cancer. 2006 Aug 21;95(4):435-44. Epub 2006 Jul 11.


Improving the referral process for familial breast cancer genetic counselling: findings of three randomised controlled trials of two interventions.

Wilson BJ, Torrance N, Mollison J, Wordsworth S, Gray JR, Haites NE, Grant A, Campbell MK, Miedyzbrodzka Z, Clarke A, Watson MS, Douglas A.

Health Technol Assess. 2005 Feb;9(3):iii-iv, 1-126. Review.


Feasibility and acceptability of providing nurse counsellor genetics clinics in primary care.

Westwood G, Pickering RM, Latter S, Lucassen A, Little P, Karen Temple I.

J Adv Nurs. 2006 Mar;53(5):591-604.


Patient satisfaction with two different models of cancer genetic services in south-east Scotland.

Holloway S, Porteous M, Cetnarskyj R, Anderson E, Rush R, Fry A, Gorman D, Steel M, Campbell H.

Br J Cancer. 2004 Feb 9;90(3):582-9.


A randomised controlled trial of breast cancer genetics services in South East Scotland: psychological impact.

Fry A, Cull A, Appleton S, Rush R, Holloway S, Gorman D, Cetnarskyj R, Thomas R, Campbell J, Anderson E, Steel M, Porteous M, Campbell H.

Br J Cancer. 2003 Aug 18;89(4):653-9.


The Birmingham Rehabilitation Uptake Maximisation Study (BRUM). Home-based compared with hospital-based cardiac rehabilitation in a multi-ethnic population: cost-effectiveness and patient adherence.

Jolly K, Taylor R, Lip GY, Greenfield S, Raftery J, Mant J, Lane D, Jones M, Lee KW, Stevens A.

Health Technol Assess. 2007 Sep;11(35):1-118. Review.


A randomised controlled trial of postoperative radiotherapy following breast-conserving surgery in a minimum-risk older population. The PRIME trial.

Prescott RJ, Kunkler IH, Williams LJ, King CC, Jack W, van der Pol M, Goh TT, Lindley R, Cairns J.

Health Technol Assess. 2007 Aug;11(31):1-149, iii-iv.


Health economics and genetic service development: a familial cancer genetic example.

Cohen D, Barton G, Gray J, Brain K.

Fam Cancer. 2004;3(1):61-7.


BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.

Shaw L, Rodgers H, Price C, van Wijck F, Shackley P, Steen N, Barnes M, Ford G, Graham L; BoTULS investigators.

Health Technol Assess. 2010 May;14(26):1-113, iii-iv. doi: 10.3310/hta14260.


A randomised comparison of UK genetic risk counselling services for familial cancer: psychosocial outcomes.

Hopwood P, Wonderling D, Watson M, Cull A, Douglas F, Cole T, Eccles D, Gray J, Murday V, Steel M, Burn J, McPherson K.

Br J Cancer. 2004 Aug 31;91(5):884-92.


Communication and information-giving in high-risk breast cancer consultations: influence on patient outcomes.

Lobb EA, Butow PN, Barratt A, Meiser B, Gaff C, Young MA, Haan E, Suthers G, Gattas M, Tucker K.

Br J Cancer. 2004 Jan 26;90(2):321-7.


The impact of genetic counselling on risk perception and mental health in women with a family history of breast cancer.

Watson M, Lloyd S, Davidson J, Meyer L, Eeles R, Ebbs S, Murday V.

Br J Cancer. 1999 Feb;79(5-6):868-74.


Risk estimation for familial breast cancer: improving the system of counselling.

Gregory H, Wordsworth S, Gibbons B, Wilson B, Haites N.

Eur J Hum Genet. 2007 Nov;15(11):1139-44. Epub 2007 Jul 18.


A randomised controlled multicentre trial of treatments for adolescent anorexia nervosa including assessment of cost-effectiveness and patient acceptability - the TOuCAN trial.

Gowers SG, Clark AF, Roberts C, Byford S, Barrett B, Griffiths A, Edwards V, Bryan C, Smethurst N, Rowlands L, Roots P.

Health Technol Assess. 2010 Mar;14(15):1-98. doi: 10.3310/hta14150.


A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context.

Buxton M, Caine N, Chase D, Connelly D, Grace A, Jackson C, Parkes J, Sharples L.

Health Technol Assess. 2006 Aug;10(27):iii-iv, ix-xi, 1-164. Review.


Health-related quality of life in early breast cancer.

Groenvold M.

Dan Med Bull. 2010 Sep;57(9):B4184.


Family history of breast cancer: what do women understand and recall about their genetic risk?

Watson M, Duvivier V, Wade Walsh M, Ashley S, Davidson J, Papaikonomou M, Murday V, Sacks N, Eeles R.

J Med Genet. 1998 Sep;35(9):731-8.

Items per page

Supplemental Content

Write to the Help Desk